2269.HK WuXi Biologics (Cayman) Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
16:43
Mar 18
Mar 18
Monetary Matters
Long WuXi biofoundry contract manufacturers
He likes Chinese biofoundry businesses, especially WuXi AppTec and WuXi Biologics, as an analog to semiconductor contract manufacturing. He argues pharma manufacturing/testing causes most FDA failures, the two companies can be part of a global oligopoly, and the U.S. Biosecure Act threat has receded.
2269.HK
WuXi Biologics (Cayman) Inc.
Long
1ST
—
—
About 2269.HK Investor Commentary
Across the available history and selected sources, Buzzberg tracks 2269.HK (WuXi Biologics (Cayman) Inc.) across 2 sources: 1 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 50% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Past 7 days, before deduplication: 1 other directions. Latest voices: Rupert Mitchell.